Five Prime Therapeutics (FPRX) Valuation Declined While Eventide Asset Management Has Cut Position by $6.01 Million; Suvretta Capital Management Has Lifted Holding in United Technologies (UTX) as Market Valuation Declined

May 18, 2018 - By Stephen Andrade

United Technologies Corporation (NYSE:UTX) Logo

Eventide Asset Management Llc decreased its stake in Five Prime Therapeutics Inc (FPRX) by 47.59% based on its latest 2017Q4 regulatory filing with the SEC. Eventide Asset Management Llc sold 286,000 shares as the company’s stock declined 22.41% with the market. The institutional investor held 315,000 shares of the health care company at the end of 2017Q4, valued at $6.91M, down from 601,000 at the end of the previous reported quarter. Eventide Asset Management Llc who had been investing in Five Prime Therapeutics Inc for a number of months, seems to be less bullish one the $645.39 million market cap company. The stock decreased 3.02% or $0.57 during the last trading session, reaching $18.33. About 94,759 shares traded. Five Prime Therapeutics, Inc. (NASDAQ:FPRX) has declined 52.34% since May 18, 2017 and is downtrending. It has underperformed by 63.89% the S&P500.




Aaron Cowen increased its stake in United Technologies Corp (UTX) by 233.86% based on its latest 2017Q4 regulatory filing with the SEC. Suvretta Capital Management Llc bought 1.40 million shares as the company’s stock declined 1.53% with the market. The hedge fund run by Aaron Cowen held 2.00 million shares of the aerospace company at the end of 2017Q4, valued at $255.55 million, up from 600,000 at the end of the previous reported quarter. Suvretta Capital Management Llc who had been investing in United Technologies Corp for a number of months, seems to be bullish on the $100.01B market cap company. The stock increased 0.31% or $0.39 during the last trading session, reaching $125. About 504,973 shares traded. United Technologies Corporation (NYSE:UTX) has risen 12.03% since May 18, 2017 and is uptrending. It has outperformed by 0.48% the S&P500.

Eventide Asset Management Llc, which manages about $1.15 billion and $1.92 billion US Long portfolio, upped its stake in Brookfield Renewable Partner (BEP) by 27,800 shares to 77,800 shares, valued at $2.72M in 2017Q4, according to the filing. It also increased its holding in Myokardia Inc by 37,000 shares in the quarter, for a total of 110,000 shares, and has risen its stake in Pattern Energy Group Inc (NASDAQ:PEGI).

Analysts await Five Prime Therapeutics, Inc. (NASDAQ:FPRX) to report earnings on August, 14. They expect $-1.33 earnings per share, up 15.82% or $0.25 from last year’s $-1.58 per share. After $-0.63 actual earnings per share reported by Five Prime Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 111.11% negative EPS growth.

More recent Five Prime Therapeutics, Inc. (NASDAQ:FPRX) news were published by: Seekingalpha.com which released: “Premarket analyst action – healthcare” on May 18, 2018. Also Seekingalpha.com published the news titled: “Five Prime Therapeutics’ (FPRX) CEO Aron Knickerbocker on Q1 2018 Results – Earnings Call Transcript” on May 13, 2018. Streetinsider.com‘s news article titled: “Goldman Sachs Starts Five Prime Therapeutics (FPRX) at Neutral” with publication date: May 10, 2018 was also an interesting one.

Investors sentiment increased to 1.34 in Q4 2017. Its up 0.30, from 1.04 in 2017Q3. It improved, as 21 investors sold FPRX shares while 29 reduced holdings. 24 funds opened positions while 43 raised stakes. 25.47 million shares or 6.30% more from 23.96 million shares in 2017Q3 were reported. Dimensional Fund Advsr Lp owns 974,276 shares. Schroder Investment Group holds 0% or 25,305 shares. Voya Invest Mgmt Ltd Liability has 0% invested in Five Prime Therapeutics, Inc. (NASDAQ:FPRX) for 12,594 shares. Legal & General Group Incorporated Plc reported 13,558 shares. Deutsche Bancshares Ag invested in 140,323 shares. The Texas-based Teacher Retirement Systems Of Texas has invested 0% in Five Prime Therapeutics, Inc. (NASDAQ:FPRX). Fifth Third Bancorporation stated it has 300 shares. California Pub Employees Retirement Sys reported 22,000 shares. United Advisers Limited Liability Com reported 0% of its portfolio in Five Prime Therapeutics, Inc. (NASDAQ:FPRX). Fmr Limited Liability invested in 0.01% or 4.34 million shares. Eventide Asset Management Ltd Co holds 0.36% of its portfolio in Five Prime Therapeutics, Inc. (NASDAQ:FPRX) for 315,000 shares. Platinum Inv Mgmt Limited holds 0.04% of its portfolio in Five Prime Therapeutics, Inc. (NASDAQ:FPRX) for 62,800 shares. 9,808 were accumulated by Cubist Systematic Strategies Limited Com. Alps Advsrs owns 0% invested in Five Prime Therapeutics, Inc. (NASDAQ:FPRX) for 32,058 shares. Public Employees Retirement Association Of Colorado has 2,495 shares.

Among 12 analysts covering Five Prime Therapeutics (NASDAQ:FPRX), 11 have Buy rating, 0 Sell and 1 Hold. Therefore 92% are positive. Five Prime Therapeutics had 26 analyst reports since July 31, 2015 according to SRatingsIntel. Jefferies maintained Five Prime Therapeutics, Inc. (NASDAQ:FPRX) on Monday, September 11 with “Buy” rating. The firm has “Buy” rating by Nomura given on Wednesday, February 28. Citigroup initiated it with “Buy” rating and $33 target in Friday, July 31 report. The stock of Five Prime Therapeutics, Inc. (NASDAQ:FPRX) has “Hold” rating given on Wednesday, September 20 by BMO Capital Markets. BMO Capital Markets upgraded the stock to “Outperform” rating in Monday, October 16 report. BMO Capital Markets initiated Five Prime Therapeutics, Inc. (NASDAQ:FPRX) rating on Tuesday, April 12. BMO Capital Markets has “Market Perform” rating and $50 target. Oppenheimer maintained the stock with “Outperform” rating in Monday, October 19 report. BMO Capital Markets maintained Five Prime Therapeutics, Inc. (NASDAQ:FPRX) rating on Monday, June 5. BMO Capital Markets has “Hold” rating and $3900 target. On Friday, March 11 the stock rating was maintained by Credit Suisse with “Outperform”. The rating was initiated by Citigroup with “Buy” on Tuesday, October 25.

More recent United Technologies Corporation (NYSE:UTX) news were published by: Seekingalpha.com which released: “Third Point (Dan Loeb) Q1 2018 Investor Letter” on May 10, 2018. Also Streetinsider.com published the news titled: “Ackman’s Pershing Square Confirms Stake in United Technologies (UTX) (more…) – 13F” on May 15, 2018. Investorplace.com‘s news article titled: “Ackman Has a Point About United Technologies Corporation Stock” with publication date: May 18, 2018 was also an interesting one.

Among 22 analysts covering United Technologies Corporation (NYSE:UTX), 13 have Buy rating, 0 Sell and 9 Hold. Therefore 59% are positive. United Technologies Corporation had 86 analyst reports since July 21, 2015 according to SRatingsIntel. The company was maintained on Friday, August 11 by RBC Capital Markets. The firm has “Outperform” rating by Daiwa Securities given on Tuesday, May 8. The rating was maintained by Jefferies on Monday, August 28 with “Buy”. Atlantic Securities downgraded the shares of UTX in report on Wednesday, July 22 to “Neutral” rating. The rating was maintained by Stifel Nicolaus on Tuesday, April 24 with “Hold”. The rating was maintained by Citigroup on Wednesday, October 21 with “Buy”. The stock of United Technologies Corporation (NYSE:UTX) earned “Buy” rating by Jefferies on Tuesday, May 30. The rating was downgraded by RBC Capital Markets on Tuesday, October 13 to “Sector Perform”. As per Thursday, January 25, the company rating was maintained by Stifel Nicolaus. Jefferies downgraded the stock to “Buy” rating in Monday, August 24 report.

Investors sentiment decreased to 0.92 in Q4 2017. Its down 0.13, from 1.05 in 2017Q3. It is negative, as 58 investors sold UTX shares while 554 reduced holdings. 121 funds opened positions while 441 raised stakes. 624.06 million shares or 0.48% more from 621.08 million shares in 2017Q3 were reported. 25 were accumulated by Hillsdale Inv Management. Blackrock owns 46.85M shares. Bridges Counsel Incorporated accumulated 9,025 shares or 0.64% of the stock. Matrix Asset Advsr has invested 3.17% in United Technologies Corporation (NYSE:UTX). Rdl Fincl reported 0.73% in United Technologies Corporation (NYSE:UTX). Gillespie Robinson & Grimm has invested 0.05% of its portfolio in United Technologies Corporation (NYSE:UTX). Capwealth stated it has 1.32% in United Technologies Corporation (NYSE:UTX). Gotham Asset Mgmt Ltd reported 90,507 shares or 0.17% of all its holdings. The Arizona-based Davis Selected Advisers has invested 4.12% in United Technologies Corporation (NYSE:UTX). The South Carolina-based Colonial Tru has invested 1.73% in United Technologies Corporation (NYSE:UTX). Dixon Hubard Feinour And Brown Va reported 14,037 shares or 0.49% of all its holdings. 144,324 were accumulated by Westpac. Regions Financial Corp holds 392,283 shares or 0.54% of its portfolio. Marathon Capital Mngmt has invested 0.09% of its portfolio in United Technologies Corporation (NYSE:UTX). Wellington Llp reported 0.37% in United Technologies Corporation (NYSE:UTX).

Since December 13, 2017, it had 1 buy, and 6 sales for $1.25 million activity. Amato Elizabeth B sold $546,600 worth of stock. $56,034 worth of United Technologies Corporation (NYSE:UTX) shares were sold by Bailey Robert J.. The insider Reynolds Fredric G bought 9,000 shares worth $1.09 million.

Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.